揭露RACK1:PI3K/AKT通路的关键调节者在前列腺癌的发展中
Cancan Lyu1, Prasanna Kuma Vaddi1, Said Elshafae1
1Departments of Neuroscience and Pharmacology, University of Iowa, Iowa City, USA.
Oncogene
|November 13, 2024
概括
激活蛋白激酶1 (RACK1) 的受体通过激活PI3K/AKT通路对前列腺癌的发展至关重要. 向RACK1可能为前列腺癌治疗提供了一个新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在癌症,包括前列腺癌中,PI3K/AKT通路经常失调.
- 直接准PI3K/AKT通路可能会导致其他致癌通路的补偿激活.
- 活性蛋白激酶1受体 (RACK1) 是一种脚手架蛋白质,在癌症信号传递中具有潜在的作用.
研究的目的:
- 研究RACK1在调节前列腺癌中的PI3K/AKT通路中的作用.
- 为了确定RACK1是否是前列腺癌的可行的治疗点.
主要方法:
- 利用前列腺癌的基因小鼠模型与PTEN和p53缺乏.
- 评估了RACK1缺乏对AKT激活,膜转位和mTORC2相互作用的影响.
- 评估了对瘤细胞增殖和瘤形成的下游影响.
- 监测HER3和雄激素受体 (AR) 表达和激活,以应对RACK1抑制.
主要成果:
- 在PTEN/p53缺乏的小鼠模型中,RACK1缺乏显著损害了AKT激活,并阻碍了前列腺瘤的形成.
- 发现RACK1促进了AKT膜转位和与mTORC2的相互作用,促进了AKT的激活.
- 通过RACK1缺陷抑制AKT激活并没有导致HER3或AR的反上调.
- RACK1在协调AKT激活和推动前列腺癌发展方面发挥着至关重要的作用.
结论:
- 在前列腺癌中,RACK1是PI3K/AKT通路的关键调节者.
- 向RACK1为前列腺癌提供了一个有前途的治疗策略,有可能避免与直接PI3K/AKT抑制剂相关的耐药性机制.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K